Author

Xihao Sherlock Hu

GV20 Therapeutics (United States)ORCID 0000-0002-3517-6351Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Approach:deep learning· 1 Assay:multiome· 1 Research Focus:perturbation response prediction· 1 Assay:scRNA-seq· 1 Approach:variational autoencoder· 1

Frequent Co-Authors

Caibin Zhou· 1 shared Chenfei WangiD· 1 shared Hailin Wei· 1 shared Pengpeng Wu· 1 shared X. Shirley LiuiD· 1 shared Xinwei Zheng· 1 shared Yazi LiiD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Caibin Zhou

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintApr 15, 2026

Decoding Single-Cell Omics of Perturbation Responses Using DeSCOPE

Pengpeng Wu, Hailin Wei, Yazi Li…·Chenfei Wang

DeSCOPE is a variational autoencoder framework for predicting genetic perturbation responses across multiple omics modalities, outperforming baselines in unseen gene and cell type scenarios.

DOI 10.64898/2026.04.13.718147

scRNA-seqATAC-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintAug 10, 2019

DeepBCR: Deep learning framework for cancer-type classification and binding affinity estimation using B cell receptor repertoires.

Xihao Sherlock Hu, X. Shirley Liu

DeepBCR predicts cancer type and binding affinity of BCRs using deep learning, validated with anti-PD1 drug affinities.

2 citations

deep learning

𝕏 PostBluesky